Subtype
Malignant Male Reproductive System Neoplasm
CI-CAN-00003180Explore in graph →
1,451 active trials27 approved drugs58 evidence items
- NCIt
- C8561
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00003180Explore in graph →
Clinical trials
6,227 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (762)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT03726320 | Trial of Community Health Worker-led Decision Coaching | completed | N/A | 162 | NYU Langone HealthOTHER | 1 | May 23, 2024 | clinicaltrials |
| NCT04604158 | Evaluating the Effect of a Mobile Audio Companion (Elly) to Reduce Anxiety in Cancer Patients | completed | N/A | 38 | Gillian GreshamOTHER | 1 | May 21, 2024 | clinicaltrials |
| NCT02573584 |
| Vascular Fingerprint Validation Study |
| completed |
| — |
| 101 |
| University Medical Center GroningenOTHER |
| 3 |
| May 17, 2024 |
| clinicaltrials |
| NCT05582759 | Sleep Hygiene Education, ReadiWatchTM Actigraphy, and Telehealth Cognitive Behavioral Training for Insomnia Effect, on Symptom Relief for Men With Prostate Cancer Receiving Androgen Deprivation Therapy(SHERE-Relief 2) | completed | N/A | 45 | University of Kansas Medical CenterOTHER | 1 | May 17, 2024 | clinicaltrials |
| NCT05527483 | Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients | completed | — | 32 | University Hospitals Cleveland Medical CenterOTHER | 1 | May 16, 2024 | clinicaltrials |
| NCT05880446 | PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)(PROCAR-BQ) | completed | N/A | 41 | Jules Bordet InstituteOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT06206993 | Effects of Kieser Resistance Training Plus Kieser Pelvic Floor Training vs. Kieser Resistance Training Plus Traditional Pelvic Floor Exercise on Urinary Incontinence in Prostate Cancer Patients After Radical Prostatectomy(RECON) | completed | N/A | 99 | University Hospital HeidelbergOTHER | 1 | May 13, 2024 | clinicaltrials |
| NCT02163317 | Magnetic Resonance Guided Focal Stereotactic Body Radiation Therapy for Localized Prostate Cancer | completed | N/A | 12 | Case Comprehensive Cancer CenterOTHER | 1 | May 10, 2024 | clinicaltrials |
| NCT03927521 | Feasibility Study on the Use of PET-MRI / 68Ga-PSMA Imaging for HIFU-focal Treatment in the Event of Recurrent Prostate Cancer After Radiotherapy - PSMA Study(PSMA) | completed | N/A | 11 | Hospices Civils de LyonOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT05127850 | MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer | completed | N/A | 51 | University of California, San FranciscoOTHER | 1 | May 8, 2024 | clinicaltrials |
| NCT04676334 | CATCH-R: A Rollover Study to Provide Continued Access to Rucaparib(CATCH-R) | completed | Phase 3 | 34 | pharmaand GmbHINDUSTRY | 6 | May 7, 2024 | clinicaltrials |
| NCT02602041 | Knowledge and Attitudes Regarding Healthy Lifestyle and Health Behavior Change in Cancer Patients and Their Partners; A Pilot Study | completed | — | 38 | University Medical Center GroningenOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT03177460 | Daratumumab or FMS Inhibitor JNJ-40346527 Before Surgery in Treating Patients With High-Risk, Resectable Localized or Locally Advanced Prostate Cancer | completed | Phase 1 | 33 | M.D. Anderson Cancer CenterOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT03358563 | Pilot Trial of Chemohormonal Therapy Followed by Prostatectomy in High Risk Prostate Cancer | completed | Early Phase 1 | 30 | University of Wisconsin, MadisonOTHER | 1 | May 3, 2024 | clinicaltrials |
| NCT00977860 | Hypofractionated SBRT For Prostate Cancer | completed | N/A | 163 | Adam OlsonOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT04726033 | 64Cu-TLX592 Phase I Safety, PK, Biodistribution and Dosimetry Study (CUPID Study)(CUPID) | completed | Early Phase 1 | 14 | Telix Pharmaceuticals (Innovations) Pty LimitedINDUSTRY | 1 | May 1, 2024 | clinicaltrials |
| NCT03572387 | A Pilot Study of 5-AZA and ATRA for Prostate Cancer With PSA-only Recurrence After Local Treatment | completed | Phase 2 | 14 | Icahn School of Medicine at Mount SinaiOTHER | 1 | Apr 30, 2024 | clinicaltrials |
| NCT04086966 | PSMA-PET/MRI for Radiation Treatment Planning in Patients With Locally Metastatic Prostate Cancer: A Pilot Study | completed | Phase 1 | 10 | University of Alabama at BirminghamOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT04742959 | Study of TT-00420 (Tinengotinib) Tablet as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors | completed | Phase 1 / Phase 2 | 203 | TransThera Sciences (Nanjing), Inc.INDUSTRY | 1 | Apr 26, 2024 | clinicaltrials |
| NCT05886751 | Randomized Trial of Trust in Online Videos About Prostate Cancer | completed | N/A | 3,649 | NYU Langone HealthOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06075498 | Comparison of Analgesia Efficacy of Transversus Abdominis Plane Block and Posterior Approach Quadratus Lumborum Block | completed | N/A | 66 | Muğla Sıtkı Koçman UniversityOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06380062 | Choline Metabolites in People With Prostate Cancer and Those With Benign Hyperplasia | completed | — | 350 | Universität des SaarlandesOTHER | 1 | Apr 25, 2024 | clinicaltrials |
| NCT06372704 | Is the HIFEM Procedure an Effective Treatment for Men With Post-prostatectomy Incontinence?(HIFEM for PPI) | completed | — | 27 | Kirsehir Ahi Evran UniversitesiOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT01641172 | Taste, Smell and Chemotherapy (TASTY)(TASTY) | completed | Phase 4 | 140 | University Medical Center GroningenOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT05376202 | Image Guided Penile Cancer Surgery(GLANS) | completed | Phase 1 | 11 | University Medical Center GroningenOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT01931644 | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | completed | — | 17,667 | Sanguine BiosciencesINDUSTRY | 1 | Apr 18, 2024 | clinicaltrials |
| NCT04028388 | ModraDoc006/r vs Docetaxel IV in Metastatic Prostate Cancer | completed | Phase 2 | 135 | Modra PharmaceuticalsINDUSTRY | 6 | Apr 17, 2024 | clinicaltrials |
| NCT05518201 | Evaluate the Safety and Immunogenicity of a 9-valent HPV Vaccine in Chinese Healthy Male Aged 9-45 Year-old | completed | Phase 1 | 90 | Shanghai Bovax Biotechnology Co., Ltd.INDUSTRY | 1 | Apr 17, 2024 | clinicaltrials |
| NCT04089553 | An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer | completed | Phase 2 | 59 | AstraZenecaINDUSTRY | 1 | Apr 16, 2024 | clinicaltrials |
| NCT04260737 | Interactive Decision Aid for Men Diagnosed With Prostate Cancer | completed | N/A | 163 | Reykjavik UniversityOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT03835533 | Platform Study for Prostate Researching Translational Endpoints Correlated to Response to Inform Use of Novel Combinations(PORTER) | completed | Phase 1 | 43 | Parker Institute for Cancer ImmunotherapyOTHER | 1 | Apr 12, 2024 | clinicaltrials |
| NCT03148795 | A Study of Talazoparib in Men With DNA Repair Defects and Metastatic Castration-Resistant Prostate Cancer | completed | Phase 2 | 128 | PfizerINDUSTRY | 14 | Apr 5, 2024 | clinicaltrials |
| NCT05736094 | Ultrasound for Detection of Prostate Cancer(SURF) | completed | N/A | 11 | Oslo University HospitalOTHER | 1 | Apr 5, 2024 | clinicaltrials |
| NCT03292874 | High Resolution MRI Study for Prostate Cancer | completed | N/A | 64 | Cedars-Sinai Medical CenterOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT03650153 | Randomized Controlled Trial of MRI Target Biopsy: Transrectal vs. Transperineal | completed | N/A | 165 | Princess Al-Johara Al-Ibrahim Cancer Research CenterOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT05772598 | Validating the 'Sexual Minorities and Prostate Cancer Scale' to Gold Standard Questionnaires(SMACS) | completed | — | 305 | Guy's and St Thomas' NHS Foundation TrustOTHER | 1 | Apr 3, 2024 | clinicaltrials |
| NCT02325557 | ADXS31-142 Alone and in Combination With Pembrolizumab (MK-3475) in Participants With Previously Treated Metastatic Castration-Resistant Prostate Cancer (mCRPC) | completed | Phase 1 / Phase 2 | 50 | Advaxis, Inc.INDUSTRY | 1 | Apr 2, 2024 | clinicaltrials |
| NCT04804839 | Comparison of the Effectiveness of Different Conservative Treatment Protocols in Postprostatectomy Urinary Incontinence | completed | N/A | 72 | Hacettepe UniversityOTHER | 1 | Mar 26, 2024 | clinicaltrials |
| NCT03419585 | The "PC-LIGHT" Study | completed | N/A | 75 | Northwestern UniversityOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT02635256 | Hypofractionated Radiosurgery for Localised Prostate Cancer(HYPOSTAT) | completed | N/A | 85 | University Hospital Schleswig-HolsteinOTHER | 1 | Mar 21, 2024 | clinicaltrials |
| NCT03822871 | A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer | completed | Phase 1 | 17 | Cancer Targeted TechnologyINDUSTRY | 1 | Mar 21, 2024 | clinicaltrials |
| NCT05252364 | A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer | completed | Phase 1 | 22 | Hinova Pharmaceuticals Aus Pty LtdINDUSTRY | 1 | Mar 21, 2024 | clinicaltrials |
| NCT03311555 | A Salvage Trial of AR Inhibition With ADT and Apalutamide With Radiation Therapy Followed by Docetaxel in Men With PSA Recurrent Prostate Cancer After Radical Prostatectomy (STARTAR) | completed | Phase 2 | 39 | Andrew J. Armstrong, MDOTHER | 1 | Mar 19, 2024 | clinicaltrials |
| NCT00789607 | Fiducial Localization and Individualized Radiotherapy -Prostate Cancer(FLIP) | completed | N/A | 17 | University Health Network, TorontoOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT01759771 | Vitamin D3 Supplementation for Low-Risk Prostate Cancer: A Randomized Trial(VD3PCa) | completed | Phase 2 | 130 | VA Office of Research and DevelopmentFED | 1 | Mar 18, 2024 | clinicaltrials |
| NCT02034955 | Prostatectomy Adaptive Radiation Therapy (ART) | completed | N/A | 21 | University Health Network, TorontoOTHER | 1 | Mar 18, 2024 | clinicaltrials |
| NCT03856437 | A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination | completed | N/A | 1,170 | University of Maryland, College ParkOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT04224740 | Pembrolizumab Combined With Cisplatin-based Chemotherapy as First-line Systemic Therapy in Advanced Penile Cancer(HERCULES) | completed | Phase 2 | 37 | Latin American Cooperative Oncology GroupOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT06214000 | Primary Care-Based Follow-up of Cancer Survivors of the Prostate and Kidney(LiVHOU) | completed | — | 178 | University Hospital, Strasbourg, FranceOTHER | 1 | Mar 13, 2024 | clinicaltrials |
| NCT06299046 | Bleeding After Robot-assisted Radical Prostatectomy: a Respective Study(UROBLOOD01) | completed | — | 194 | Fondazione IRCCS Ca' Granda, Ospedale Maggiore PoliclinicoOTHER | 1 | Mar 8, 2024 | clinicaltrials |
Data updated 24 days agoSource updated May 23, 2024source: clinicaltrials